Characterization of follistatin-type domains and their contribution to myostatin and activin A antagonism

Molecular Endocrinology

Volumn 26, Issue 7, 2012, Pages 1167-1178

  Cash, Jennifer N ^a   Angerman, Elizabeth B ^a   Keutmann, Henry T ^b   Thompson, Thomas B ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN A; FOLLISTATIN LIKE 3; FOLLISTATIN RELATED PROTEIN; FST ND FSD1 FSD1 PROTEIN; MYOSTATIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; COMPLEX FORMATION; ENZYME INHIBITION; LIGAND BINDING; POINT MUTATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN CROSS LINKING; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; PROTEIN PURIFICATION;

ACTIVINS; ANIMALS; CELL LINE; FOLLISTATIN; FOLLISTATIN-RELATED PROTEINS; HEK293 CELLS; HUMANS; MICE; MYOSTATIN; PROTEIN BINDING; PROTEIN STRUCTURE, QUATERNARY; PROTEIN STRUCTURE, TERTIARY;

EID: 84863321239     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2012-1061     Document Type: Article

References (48)

1. Nakamura T, Takio K, Eto Y, Shibai H, Titani K, Sugino H 1990 Activin-binding protein from rat ovary is follistatin. Science 247: 836-838
2. Matzuk MM, Kumar TR, Bradley A 1995 Different phenotypes for mice deficient in either activins or activin receptor type II. Nature 374:356-360
3. Xia Y, Schneyer AL 2009 The biology of activin: recent advances in structure, regulation and function. J Endocrinol 202:1-12
4. Lee SJ 2004 Regulation of muscle mass by myostatin. Annu Rev Cell Dev Biol 20:61-86
5. McPherron AC, Lawler AM, Lee SJ 1997 Regulation of skeletal muscle mass in mice by a new TGF-β superfamily member. Nature 387:83-90
6. Hayette S, Gadoux M, Martel S, Bertrand S, Tigaud I, Magaud JP, Rimokh R 1998 FLRG (follistatin-related gene), a new target of chromosomal rearrangement in malignant blood disorders. Oncogene 16:2949-2954
7. Ueno N, Ling N, Ying SY, Esch F, Shimasaki S, Guillemin R 1987 Isolation and partial characterization of follistatin: a single-chain Mr 35,000 monomeric protein that inhibits the release of follicle-stimulating hormone. Proc Natl Acad Sci USA 84:8282-8286
8. Matzuk MM, Lu N, Vogel H, Sellheyer K, Roop DR, Bradley A 1995 Multiple defects and perinatal death in mice deficient in follistatin. Nature 374:360-363
9. Brown ML, Bonomi L, Ungerleider N, Zina J, Kimura F, Mukher-jee A, Sidis Y, Schneyer A 2011 Follistatin and follistatin like-3 differentially regulate adiposity and glucose homeostasis. Obesity 19:1940-1949
10. Mukherjee A, Sidis Y, Mahan A, Raher MJ, Xia Y, Rosen ED, Bloch KD, Thomas MK, Schneyer AL 2007 FSTL3 deletion reveals roles for TGF-β family ligands in glucose and fat homeostasis in adults. Proc Natl Acad Sci USA 104:1348-1353
11. Hashimoto O, Nakamura T, Shoji H, Shimasaki S, Hayashi Y, Sugino H 1997 A novel role of follistatin, an activin-binding protein, in the inhibition of activin action in rat pituitary cells. Endo-cytotic degradation of activin and its acceleration by follistatin associated with cell-surface heparan sulfate. J Biol Chem272:13835-13842
12. Sidis Y, Schneyer AL, Keutmann HT 2005 Heparin and activin-binding determinants in follistatin and FSTL3. Endocrinology 146: 130-136
13. Allendorph GP, Vale WW, Choe S 2006 Structure of the ternary signaling complex of a TGF-β superfamily member. Proc Natl Acad Sci USA 103:7643-7648
14. Greenwald J, Groppe J, Gray P, Wiater E, Kwiatkowski W, Vale W, Choe S 2003 The BMP7/ActRII extracellular domain complex provides new insights into the cooperative nature of receptor assembly. Mol Cell 11:605-617
15. Keller S, Nickel J, Zhang JL, Sebald W, Mueller TD 2004 Molecular recognition of BMP-2 and BMP receptor IA. Nat Struct Mol Biol 11:481-488
16. Kirsch T, Sebald W, Dreyer MK 2000 Crystal structure of the BMP-2-BRIA ectodomain complex. Nat Struct Biol 7:492-496
17. Weber D, Kotzsch A, Nickel J, Harth S, Seher A, Mueller U, Sebald W, Mueller TD 2007 A silent H-bond can be mutationally activated for high-affinity interaction of BMP-2 and activin type IIB receptor. BMC Struct Biol 7:6
18. Thompson TB, Woodruff TK, Jardetzky TS 2003 Structures of an ActRIIB:activin A complex reveal a novel binding mode for TGF-β ligand:receptor interactions. EMBO J 22:1555-1566
19. Groppe J, Hinck CS, Samavarchi-Tehrani P, Zubieta C, Schuer-mann JP, Taylor AB, Schwarz PM, Wrana JL, Hinck AP 2008 Cooperative assembly of TGF-β superfamily signaling complexes is mediated by two disparate mechanisms and distinct modes of receptor binding. Mol Cell 29:157-168
20. Hart PJ, Deep S, Taylor AB, Shu Z, Hinck CS, Hinck AP 2002 Crystal structure of the human TβR2 ectodomain-TGF-β3 complex. Nat Struct Biol 9:203-208
21. Kotzsch A, Nickel J, Seher A, Sebald W, Müller TD 2009 Crystal structure analysis reveals a spring-loaded latch as molecular mechanism for GDF-5-type I receptor specificity. EMBO J 28:937-947
22. Innis CA, Shi J, Blundell TL 2000 Evolutionary trace analysis of TGF-β and related growth factors: implications for site-directed mutagenesis. Protein Eng 13:839-847
23. Sidis Y, Mukherjee A, Keutmann H, Delbaere A, Sadatsuki M, Schneyer A 2006 Biological activity of follistatin isoforms and fol-listatin-like-3 is dependent on differential cell surface binding and specificity for activin, myostatin, and bone morphogenetic proteins. Endocrinology 147:3586-3597
24. Iemura S, Yamamoto TS, Takagi C, Uchiyama H, Natsume T, Shimasaki S, Sugino H, Ueno N 1998 Direct binding of follistatin to a complex of bone-morphogenetic protein and its receptor inhibits ventral and epidermal cell fates in early Xenopus embryo. Proc Natl Acad Sci USA 95:9337-9342
25. Cash JN, Angerman EB, Kattamuri C, Nolan K, Zhao H, Sidis Y, Keutmann HT, Thompson TB 2012 The structure of myostatin: follistatin-like 3: N-terminal domains of follistatin-type molecules exhibit alternate modes of binding. J Biol Chem 287:1043-1053
26. Nakatani M, Takehara Y, Sugino H, Matsumoto M, Hashimoto O, Hasegawa Y, Murakami T, Uezumi A, Takeda S, Noji S, Sunada Y, Tsuchida K 2008 Transgenic expression of a myostatin inhibitor derived from follistatin increases skeletal muscle mass and ameliorates dystrophic pathology in mdx mice. FASEB J 22:477-487
27. Takehara-Kasamatsu Y, Tsuchida K, Nakatani M, Murakami T, Kurisaki A, Hashimoto O, Ohuchi H, Kurose H, Mori K, Kagami S, Noji S, Sugino H 2007 Characterization of follistatin-related gene as a negative regulatory factor for activin family members during mouse heart development. J Med Invest 54:276-288
28. Cash JN, Rejon CA, McPherron AC, Bernard DJ, Thompson TB 2009 The structure of myostatin:follistatin288: insights into receptor utilization and heparin binding. EMBO J 28:2662-2676
29. Lerch TF, Shimasaki S, Woodruff TK, Jardetzky TS 2007 Structural and biophysical coupling of heparin and activin binding to follistatin isoform functions. J Biol Chem 282:15930-15939
30. Stamler R, Keutmann HT, Sidis Y, Kattamuri C, Schneyer A, Thompson TB 2008 The structure of FSTL3.activin A complex. Differential binding of N-terminal domains influences follistatin-type antagonist specificity. J Biol Chem 283:32831-32838
31. Thompson TB, Lerch TF, Cook RW, Woodruff TK, Jardetzky TS 2005 The structure of the follistatin:activin complex reveals antagonism of both type I and type II receptor binding. Dev Cell 9:535-543
32. Harrington AE, Morris-Triggs SA, Ruotolo BT, Robinson CV, Ohnuma S, Hyvönen M 2006 Structural basis for the inhibition of activin signalling by follistatin. EMBO J 25:1035-1045
33. Schneyer AL, Sidis Y, Gulati A, Sun JL, Keutmann H, Krasney PA 2008 Differential antagonism of activin, myostatin and growth and differentiation factor 11 by wild-type and mutant follistatin. Endocrinology 149:4589-4595
34. Harrison CA, Chan KL, Robertson DM 2006 Activin-A binds follistatin and type II receptors through overlapping binding sites: generation of mutants with isolated binding activities. Endocrinology 147:2744-2753
35. Keutmann HT, Schneyer AL, Sidis Y 2004 The role of follistatin domains in follistatin biological action. Mol Endocrinol 18:228-240
36. Sidis Y, Schneyer AL, Sluss PM, Johnson LN, Keutmann HT 2001 Follistatin: essential role for the N-terminal domain in activin binding and neutralization. J Biol Chem 276:17718-17726
37. Nakatani M, Kokubo M, Ohsawa Y, Sunada Y, Tsuchida K 2011 Follistatin-derived peptide expression in muscle decreases adipose tissue mass and prevents hepatic steatosis. Am J Physiol Endocrinol Metab 300:E543-E553
38. Schneyer AL, Rzucidlo DA, Sluss PM, Crowley WF 1994 Characterization of unique binding kinetics of follistatin and activin or inhibin in serum. Endocrinology 135:667-674
39. Dennler S, Itoh S, Vivien D, ten Dijke P, Huet S, Gauthier JM 1998 Direct binding of Smad3 and Smad4 to critical TGF β-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J 17:3091-3100
40. Hill AV 1910 Proceedings of the Physiological Society: January 22, 1910. J Physiol 40:iv-vii
41. Knaus P, Sebald W 2001 Cooperativity of binding epitopes and receptor chains in the BMP/TGFβ superfamily. Biol Chem 382: 1189-1195
42. Huang T, David L, Mendoza V, Yang Y, Villarreal M, De K, Sun L, Fang X, López-Casillas F, Wrana JL, Hinck AP 2011 TGF-β signalling is mediated by two autonomously functioning T/3RI:T/3RII pairs. EMBO J 30:1263-1276
43. Isaacs MJ, Kawakami Y, Allendorph GP, Yoon BH, Izpisua Belmonte JC, Choe S 2010 Bone morphogenetic protein-2 and -6 heterodimer illustrates the nature of ligand-receptor assembly. Mol Endocrinol 24:1469-1477
44. Shi M, Zhu J, Wang R, Chen X, Mi L, Walz T, Springer TA 2011 Latent TGF-β structure and activation. Nature 474:343-349
45. Groppe J, Greenwald J, Wiater E, Rodriguez-Leon J, Economides AN, Kwiatkowski W, Affolter M, Vale WW, Belmonte JC, Choe S 2002 Structural basis of BMP signalling inhibition by the cystine knot protein Noggin. Nature 420:636-642
46. Zhang JL, Qiu LY, Kotzsch A, Weidauer S, Patterson L, Hammer-schmidt M, Sebald W, Mueller TD 2008 Crystal structure analysis reveals how the Chordin family member crossveinless 2 blocks BMP-2 receptor binding. Dev Cell 14:739-750
47. Greenwald J, Vega ME, Allendorph GP, Fischer WH, Vale W, Choe S 2004 A flexible activin explains the membrane-dependent cooperative assembly of TGF-β family receptors. Mol Cell 15:485-489
48. DeLano WL 2002 The PyMOL molecular graphics system. Palo Alto, CA: DeLano Scientific